No Detail Found!

FREQUENCY AND CORRELATES OF MYOPATHY IN PATIENTS WITH DIABETES TAKING ATORVASTATIN

Author(s)
Kamil Rehman Butt Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Rawalpindi,Pakistan
Andaleeb Khan Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Rawalpindi,Pakistan
Ali Muhammad Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Rawalpindi,Pakistan
Jawad Khan Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,Rawalpindi,Pakistan
Ejaz Ali *Combined Military Hospital Quetta/National University of Medical Sciences (NUMS) Pakistan,
Usama Bin Zubair Pakistan Institute of Medical Sciences, Islamabad Pakistan
Abstract
Objective: To determine the myopathy in patients with diabetes taking atorvastatin and look for the factors correlated with the presence of myopathy among these patients. Study Design: Cross sectional analytical study. Place and Duration of Study: Department of Medicine, Pak Emirates Military Hospital Rawalpindi from, Jul to Dec 2018. Methodology: A total of 166 patients of both genders with type 2 diabetes mellitus taking atorvastatin for at least three to twelve months were included. Blood samples were drawn and Creatinine kinase (CK) levels were determined by automated analysis by colorimetry. Myopathy was taken as muscle symptoms associated with elevations in Creatinine Kinase at least 10 times the upper limit of normal. Results: Mean age of patients was 51.530 ± 5.70 years with age range from 40-70 years with. Mean duration of diabetes was 6.174 ± 2.27 years, mean duration of taking atorvastatin 7.186 ± 2.17 months and mean creatinine kinase levels were 1760.325 ± 5111.71 IU/L. Males were 68.7% as compare to females 31.3%. Myopathy was seen in 8.4% patients. Long duration of Diabetes Mellitus and atorvastatin use was statistically significantly related with the presence of myopathy. Conclusion: Myopathy was found in a significant number of patients taking atorvastatin. High risk population in our study emerged out to be patients with long duration of Diabetes Mellitus and long use of atorvastatin.
Publication Details
Page(s) 482-485
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 71, Issue: 2, Year: 2021

Request the full text from PASTIC

Keywords
Diabetes Mellitus, Atorvastatin, Myopathy.
0

Citations

0

Downloads

131

Views